Nihon Pharmaceuticals To Transfer ES Polytamin Granules To Ajinomoto
This article was originally published in PharmAsia News
Executive Summary
Ajinomoto Pharmaceuticals and Nihon Pharmaceuticals announced July 31 that Ajinomoto will get manufacturing and sales approval for essential amino acid ES Polytamin granules from Sept. 1 onwards, after which both companies will sell the product.